SYBX SYNLOGIC, INC.
Mergers ·
The combined company would operate as Caldera Therapeutics. A concurrent private placement of approximately $278 million is expected to close alongside the merger, which is expected to close by early 2027.
We have not published a story on SYNLOGIC, INC. yet. When there is news, it will appear here.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $0 | $8,000 |
| Research and development | $43,000 | $9.2 million |
| Net income (loss) | -$1.0 million | -$23.4 million |
| Cash from operations | -$4.4 million | -$31.7 million |
| Cash and equivalents | $14.7 million | $18.9 million |
| Short-term investments | $0 |
Our latest story on this, dated Jul 29, 2026: "Synlogic to merge with Caldera Therapeutics in all-stock deal". The story links the filing or release it is based on. Read the story.
Our latest story on this, dated Jul 29, 2026: "Synlogic to merge with Caldera Therapeutics in all-stock deal". The story links the filing or release it is based on. Read the story.
SYNLOGIC, INC. trades under the ticker SYBX on OTC.
SYNLOGIC, INC. is listed on OTC.
Our directory records SYNLOGIC, INC. under United States.
aibio.space lists SYNLOGIC, INC. among 2,820 public biotech companies and publishes its news here as stories appear.
$0 for the fiscal year ended Dec 31, 2025, as reported to the SEC.
SYNLOGIC, INC. reported a net loss of $1.0 million for the fiscal year ended Dec 31, 2025, and used $4.4 million of cash in operations, per its annual report to the SEC.
$43,000 in the fiscal year ended Dec 31, 2025, per its annual report.
$13.2 million in cash at Jun 30, 2026, per its 10-Q.
Our latest story on SYNLOGIC, INC., dated Jul 29, 2026: "Synlogic to merge with Caldera Therapeutics in all-stock deal". The combined company would operate as Caldera Therapeutics. A concurrent private placement of approximately $278 million is expected to close alongside the merger, which is expected to close by early 2027. Source.
Press Follow on this page to add SYNLOGIC, INC. to your Following list, or subscribe to the aibio.space newsletter. We have published 1 story naming SYNLOGIC, INC. so far, in Mergers.
Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction
aibio